OTIPAX Ear Drops

What is OTIPAX

OTIPAX is a combination medication used for the local treatment of ear pain (otalgia), particularly due to middle ear inflammation such as otitis media. It contains two active ingredients:

• Lidocaine: a fast-acting local anesthetic that provides temporary relief from ear pain.
• Phenazone (Antipyrine): an anti-inflammatory and analgesic agent that reduces inflammation and pain in the ear.

OTIPAX is formulated as an otic (ear) solution and is typically available in a 15 ml vial accompanied by a dropper for easy administration. It is particularly effective in pediatric populations and adults alike when the tympanic membrane (eardrum) is intact.

How to use OTIPAX

Proper use of OTIPAX ensures effectiveness and minimizes complications:

• Wash hands thoroughly before handling the dropper or touching the ear.
• Warm the bottle by holding it in your hands for a few minutes to avoid dizziness due to cold drops.
• Lie down or tilt the head to one side with the affected ear facing upwards.
• Instill 4 drops into the affected ear 2–3 times daily, or as directed by your physician.
• Keep the head tilted for a few minutes to allow the drops to penetrate properly.
• Do not insert cotton swabs or other objects into the ear after applying the drops.

Always follow your doctor’s instructions and the package leaflet. Treatment duration should not exceed 10 days without reassessment.

Mode of Action OTIPAX

OTIPAX combines a local anesthetic and an anti-inflammatory agent to provide dual relief:

• Lidocaine: Blocks sodium channels in nerve membranes, preventing the initiation and transmission of pain signals, resulting in quick and effective anesthesia.
• Phenazone: Inhibits prostaglandin synthesis and reduces inflammation in the middle ear. This also contributes to reducing pain and swelling.

The combination offers symptomatic relief from ear pain without systemic side effects. The formulation does not penetrate the bloodstream significantly when used correctly, making it suitable for local use without major systemic effects.

OTIPAX Interactions OTIPAX

Since OTIPAX is a locally acting drug and not absorbed systemically in significant amounts, the risk of interactions with other medications is low. However:

• Do not use with other otic solutions unless prescribed by your doctor.
• If a ruptured tympanic membrane is suspected, avoid using OTIPAX, as it may allow systemic absorption and increase the risk of ototoxicity, especially if combined with aminoglycoside antibiotics.
• Inform your doctor about any medications or ear drops you are currently using.

Always consult your healthcare provider if you’re uncertain about potential drug interactions.

Dosage of OTIPAX

The standard dosing for OTIPAX is:

• Adults and children: 4 drops into the affected ear, 2 to 3 times daily.
• Maximum treatment duration: 10 days, unless otherwise advised by a physician.

Dose adjustment is not typically needed based on age or weight, but a physician’s supervision is recommended for infants or very young children. Do not exceed the recommended dose or duration of use. Discontinue treatment if symptoms worsen or fail to improve after a few days.

Possible side effects of OTIPAX

OTIPAX is generally well-tolerated, but some individuals may experience side effects:

• Localized reactions: such as itching, irritation, or redness in the ear canal.
• Allergic reactions: though rare, may present as rash, swelling, or increased ear discomfort.
• Temporary hearing changes: due to the presence of fluid or inflammation in the middle ear; not caused directly by OTIPAX but should be monitored.

If any unusual or persistent symptoms occur, discontinue use and consult a healthcare provider. Always check for hypersensitivity to lidocaine or phenazone before starting therapy.

OTIPAX Contraindications OTIPAX

OTIPAX should not be used in the following conditions:

• Perforated tympanic membrane (eardrum): Using OTIPAX in such cases can lead to inner ear toxicity.
• Hypersensitivity to lidocaine, phenazone, or any excipients in the formulation.
• Chronic otitis media with discharge: Should be evaluated by a physician prior to use.

Use in pregnancy and breastfeeding is generally considered safe due to low systemic absorption, but medical advice is always recommended before use.

Storage of OTIPAX

To maintain OTIPAX’s efficacy and safety:

• Store below 30°C (86°F) in a dry place away from direct sunlight and moisture.
• Do not refrigerate or freeze.
• Keep the vial tightly closed when not in use.
• Keep out of reach of children.
• Once opened, use within one month to avoid contamination.

Check the expiry date before each use. Do not use if the solution is cloudy or has particles.